Dr. Mody is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
11 Erin Court
Edison, NJ 08817- Is this information wrong?
Education & Training
- Rowan University School of Osteopathic MedicineClass of 2024
Publications & Presentations
PubMed
- 1 citationsTirzepatide 10 and 15 mg vs semaglutide 2.0 mg: A long-term cost-effectiveness analysis in patients with type 2 diabetes in the United States.Reema Mody, William J Valentine, Meredith Hoog, Helen Sharland, Mark Belger> ;Journal of Managed Care & Specialty Pharmacy. 2024 Feb 3
- Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United States.Kellie L Meyer, Jennifer M Ward, Ken B O'Day, Reema R Mody> ;Diabetes Therapy. 2023 Dec 1
- 5 citationsLong-term cost-effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States.William J Valentine, Meredith Hoog, Mark Belger, Richard Pollock, Reema Mody> ;Diabetes, Obesity & Metabolism. 2023 May 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: